SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- obesity/erectile dysfunction
An SI Board Since February 2001
Posts SubjectMarks Bans
435 30 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60GSK / Wellbutrin LOS ANGELES, Feb 25 (Reuters) - The antidepressant Wellbutrin nigel bates-2/26/2002
59SNPs and obesity, a tool, haven't played with it yet...... web.bioinformatiscaram(o)uche-2/24/2002
58United States Patent Application 20020004512 Kind Code A1 Bakshi, Raman Kumscaram(o)uche-2/21/2002
57Proc. Natl. Acad. Sci. USA, Vol. 99, Issue 4, 1921-1925, February 19, 2002 BiocMiljenko Zuanic-2/19/2002
56Roche and Vernalis Sign New Research and Development Agreement On Anti-Obesity Dnigel bates-2/11/2002
55[ Metabolic Pharmaceuticals/AOD9604 ] Endocrinology 2001 Dec;142(12):5182-9 Tscaram(o)uche-2/5/2002
54Tuesday February 5, 10:09 am Eastern Time Press Release SOURCE: Metabolic PharmaMiljenko Zuanic-2/5/2002
53[ Topiramate anti-epileptic/JNJ/obesity ] Message 17010273scaram(o)uche-2/4/2002
52[ NSTK partners apomorphine ] Monday February 4, 7:00 am Eastern Time Press Relscaram(o)uche-2/4/2002
51Langer et al...... in the penalty box. Thanks!scaram(o)uche-1/21/2002
50This one is the patent number (6,306,819 ) in the NYT story and seems to fit themichael_f_murphy-1/21/2002
49Nature. AMPK pathway and leptin. Molecular Link Between Diabetes, Obesity keokalani'nui-1/18/2002
48[ VVUS/another PDE5 inhibitor ] Thursday January 17, 1:33 pm Eastern Time Pressscaram(o)uche-1/17/2002
47Cool. Is the abstract the one licensed to Repair, Inc.?scaram(o)uche-1/13/2002
46angiostatin and endostatin, on ob/ob mice From the new York Times: nytimes.commichael_f_murphy-1/7/2002
45[ PTN/melanotan-II/PT-141 ] Message 16868630scaram(o)uche-1/6/2002
44Published online before print December 26, 2001 Proc. Natl. Acad. Sci. USA, 10.1Miljenko Zuanic-12/26/2001
43[ phase II, nasal apomorhine/NSTK ] Message 16792796scaram(o)uche-12/14/2001
42Wednesday December 5, 2:15 am Eastern Time Press Release SOURCE: Phytopharm plc Miljenko Zuanic-12/5/2001
41Here's the abstract. I can't tell if there's some double talk here,scaram(o)uche-11/17/2001
40Thursday November 15, 7:31 am Eastern Time Press Release SOURCE: Palatin Technscaram(o)uche-11/15/2001
39WESTPORT, CT (Reuters Health) Nov 08 - A little-known fatty compound produced innigel bates-11/10/2001
38Obesity. ABT. Meridia. Short term results. Weight Loss Shown in Preliminary Stukeokalani'nui-10/8/2001
37If Bupropion is what they have in mind, than it is FAR from blockbuster, imo. MMiljenko Zuanic-10/8/2001
36LEXG has a target enzyme "LG-314." THE WOODLANDS, Texas, Oct. 1 /PRNkeokalani'nui-10/1/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News